Mahin Alamgir, MD
Dermatology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · West Coast Skin and Cancer Medical Center Inc · 4 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alamgir’s office at (559) 446-0289 to ask if they take your plan before you enroll.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 39 | More than 70% of doctors who do this |
| Skin biopsy | 14 | More than 61% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 545 | 70 |
| Destruction of precancer skin growth, 1 growth | 122 | 13 |
| Biopsy of related skin growth, first growth | 126 | – |
| Biopsy of related skin growth, each additional growth | 79 | – |
| Destruction of skin growth, 1-14 growths | 29 | – |
| Destruction of precancer skin growth, 15 or more growths | 16 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Year by year
| 2023 | 31 | 131 | 74 | 0.95 | $14,917 | $3,434 |
| 2022 | 220 | 1,327 | 74 | 0.88 | $154,038 | $48,170 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 16 | $787 | $49 |
| Destruction of precancer skin growth, 1 growth | 13 | $348 | $27 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $100 | $1 |
2022: 11 services
| New patient visit (45+ min) | 110 | $11,721 | $107 |
| Return visit (30+ min) | 109 | $10,213 | $78 |
| Destruction of precancer skin growth, 1 growth | 106 | $5,014 | $41 |
| Biopsy of related skin growth, first growth | 115 | $2,871 | $23 |
| Long return visit (40+ min) | 18 | $2,554 | $116 |
| Destruction of skin growth, 1-14 growths | 25 | $1,564 | $54 |
| New patient visit (30+ min) | 24 | $1,534 | $64 |
| Biopsy of related skin growth, each additional growth | 43 | $1,382 | $17 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $1,251 | $78 |
| Short return visit (20+ min) | 16 | $910 | $51 |
| Destruction of precancer skin growth, 2-14 growths | 89 | $894 | $2 |
Medicaid work
$970 in 2022
Medicaid paid $970 for 17 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 17 | $970 |
| 2022 | 17 | 1 | 15 | $970 |
Drugs they prescribed that Part D paid
$31,940
Pharmacies billed $31,940 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
139 generic and fewer than 11 brand-name prescriptions · $31,940 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 15 | $479 | $32 |
| Triamcinolone Acetonide | 23 | $239 | $10 |
| Hydrocortisone | 25 | $113 | $5 |
Year by year
| 2024 | 146 | 60 | None | None | $31,940 |
| 2023 | 63 | 33 | 0% (0) | 0% | $1,480 |
| 2022 | 172 | 83 | 0% (0) | None | $5,036 |
| 2019 | 71 | 12 | 0% (0) | 73% | $120,053 |
| 2018 | 94 | 24 | 0% (0) | 18% | $14,917 |
| 2017 | 176 | 35 | None | 24% | $14,666 |
| 2016 | 186 | 39 | None | 28% | $19,171 |
| 2015 | 12 | None | None | None | $193 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Triamcinolone Acetonide | 18 | $443 | $25 |
2022: 4 drugs
| Triamcinolone Acetonide | 47 | $987 | $21 |
| Clobetasol Propionate | 12 | $868 | $72 |
| Ketoconazole | 19 | $533 | $28 |
| Hydrocortisone | 22 | $189 | $9 |
2019: 1 drug
| Atripla | 11 | $31,266 | $2,842 |
2017: 1 drug
| Clopidogrel | 11 | $61 | $6 |
Money from drug and device companies
$1,541 in 2025
| 2025 | 15 | 57 | None | $1,541 |
| 2024 | 9 | 20 | None | $805 |
| 2023 | 1 | 1 | None | $114 |
| 2022 | 2 | 2 | None | $32 |
| 2021 | 4 | 10 | None | $160 |
| 2020 | 3 | 6 | None | $148 |
| 2019 | 4 | 4 | None | $260 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $354 | 17 payments
|
| Regeneron Healthcare Solutions | Dupixent | $277 | 4 payments
|
| Incyte | Opzelura | $212 | 8 payments
|
| Organon | Vtama | $170 | 10 payments
|
| Ucb | Bimzelx | $164 | 3 payments
|
| LEO Pharma | Adbry | $104 | 5 payments
|
See all 57 published payments
| Organon | Meals · 2025-12-22 | None | $4 |
| Organon | Meals · 2025-12-17 | Vtama | $10 |
| Abbvie | Meals · 2025-12-16 | Rinvoq | $5 |
| Organon | Meals · 2025-12-03 | Vtama | $10 |
| Organon | Meals · 2025-11-19 | None | $9 |
| Abbvie | Meals · 2025-11-17 | Skyrizi | $16 |
| Abbvie | Meals · 2025-11-13 | Skyrizi | $14 |
| Incyte | Meals · 2025-11-07 | Opzelura | $27 |
| Biofrontera | Meals · 2025-11-05 | None | $20 |
| Organon | Meals · 2025-11-05 | None | $5 |
| Novartis Pharmaceuticals | Meals · 2025-10-22 | Cosentyx | $14 |
| Organon | Meals · 2025-10-17 | Nexplanon | $6 |
| Organon | Meals · 2025-10-15 | Nexplanon | $6 |
| Abbvie | Meals · 2025-10-10 | Skyrizi | $25 |
| Abbvie | Meals · 2025-10-09 | Skyrizi | $4 |
| Organon | Meals · 2025-10-08 | Nexplanon | $24 |
| Incyte | Meals · 2025-10-05 | Opzelura | $11 |
| LEO Pharma | Meals · 2025-09-30 | Adbry | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-09-23 | Dupixent | $21 |
| Abbvie | Meals · 2025-09-17 | Rinvoq | $26 |
| Abbvie | Meals · 2025-09-03 | Rinvoq | $34 |
| Surgenex | Meals · 2025-09-03 | Surgraft | $15 |
| Abbvie | Meals · 2025-09-02 | Skyrizi | $20 |
| Botanix SB | Meals · 2025-08-28 | Sofdra | $17 |
| Incyte | Meals · 2025-08-26 | Opzelura | $3 |
| Incyte | Meals · 2025-08-26 | Opzelura | $9 |
| LEO Pharma | Meals · 2025-08-19 | Adbry | $19 |
| Novartis Pharmaceuticals | Meals · 2025-08-12 | Cosentyx | $28 |
| Abbvie | Meals · 2025-07-23 | Botox | $24 |
| Abbvie | Meals · 2025-07-22 | Skyrizi | $32 |
| Incyte | Meals · 2025-07-15 | Opzelura | $10 |
| Incyte | Meals · 2025-07-06 | Opzelura | $3 |
| Abbvie | Meals · 2025-07-01 | Rinvoq | $4 |
| Regeneron Healthcare Solutions | Meals · 2025-07-01 | Dupixent | $19 |
| Incyte | Meals · 2025-06-26 | Opzelura | $25 |
| Sun Pharmaceutical Industries | Meals · 2025-06-25 | Ilumya | $20 |
| Incyte | Meals · 2025-06-24 | Opzelura | $124 |
| LEO Pharma | Meals · 2025-06-24 | Adbry | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-06-19 | Dupixent | $125 |
| Galderma Laboratories L.P. | Meals · 2025-06-05 | Nemluvio | $22 |
| Abbvie | Meals · 2025-06-03 | Skyrizi | $12 |
| LEO Pharma | Meals · 2025-06-03 | Adbry | $15 |
| LEO Pharma | Meals · 2025-05-27 | Adbry | $32 |
| Abbvie | Meals · 2025-05-21 | Skyrizi | $9 |
| Ucb | Meals · 2025-05-20 | Bimzelx | $89 |
| Abbvie | Meals · 2025-05-06 | Rinvoq | $4 |
| Abbvie | Meals · 2025-04-30 | Skyrizi | $98 |
| Abbvie | Meals · 2025-04-02 | Botox | $23 |
| Organon | Meals · 2025-03-25 | Vtama | $85 |
| Amgen | Meals · 2025-03-19 | Otezla | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-03-08 | Dupixent | $112 |
| Genzyme | Meals · 2025-03-08 | Dupixent | $90 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $5 |
| Ucb | Meals · 2025-02-11 | Bimzelx | $37 |
| Organon | Meals · 2025-01-09 | Vtama | $11 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-08 | Sotyktu | $17 |
| Ucb | Meals · 2025-01-07 | Bimzelx | $39 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $805
| Dermavant Sciences | Vtama | $220 | 5 payments
|
| Amgen | Otezla | $177 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $173 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $98 | 1 payment
|
| Incyte | Opzelura | $33 | 2 payments
|
| Abbvie | Rinvoq | $30 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $29 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $25 | 1 payment
|
| Janssen Biotech | Tremfya | $21 | 1 payment
|
2023: $114
| Amgen | Otezla | $114 | 1 payment
|
2022: $32
| Incyte | Opzelura | $18 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $14 | 1 payment
|
2021: $160
| AbbVie | Skyrizi | $83 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $48 | 2 payments
|
| Ucb | Cimzia | $15 | 1 payment
|
| Incyte | Opzelura | $15 | 1 payment
|
2020: $148
| Regeneron Healthcare Solutions | Dupixent | $116 | 4 payments
|
| Genentech USA | Erivedge | $18 | 1 payment
|
| AbbVie | Skyrizi | $14 | 1 payment
|
2019: $260
| Allergan | Avycaz | $125 | 1 payment
|
| Ferring Pharmaceuticals | Firmagon | $104 | 1 payment
|
| AbbVie | Humira | $17 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $13 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| PFIZER INC. · Presto Characterization and Clinical Outcomes of Alopecia Aerata Aa Patients Treated With Ritlecitinib in A Realworld Rw Cohort A Multinational Prospective Observational Study · 2025 | Their institution | $2,828 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 78.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619351897
- Licence
- NH 22094
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 51 Railroad St, Keene, NH, 03431
- NPI first listed
- 2015-07-16
- NPI last updated
- 2022-07-29
- NPI record certified
- 2022-07-29
This is when the NPI record was last certified, not a medical board exam.